The ophthalmic drugs market is estimated to be valued at US$ 48.19 Bn in 2023 and is expected to exhibit a CAGR of 5.6% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
The ophthalmic drugs market comprises drugs used in the treatment of various eye diseases and disorders. The major products include anti-glaucoma drugs, dry eye drugs, retinal ... Read more

Ophthalmic drugs are used for the treatment of several eye diseases and disorders such as glaucoma, conjunctivitis, dry eye syndrome, infection, inflammation, and retinal disorders. Growing prevalence of various eye disorders, rise in ageing population and increasing healthcare expenditures are some key factors driving the demand for ophthalmic drugs.

The global Ophthalmic Drugs Market is estimated to be valued at US$ 48.19 Bn in 2023 and is expected to exhibit a ... Read more